The biologic rationale of hyperthermia

Peritoneal Carcinomatosis: A Multidisciplinary Approach

Volumn , Issue , 2007, Pages 171-184

  Hildebrandt, Bert ^a   Wust, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; APOPTOSIS; HUMAN; HYPERTHERMIC THERAPY; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; REVIEW;

ANIMALS; APOPTOSIS; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; IMMUNE SYSTEM; NEOPLASMS;

EID: 84875021936     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-48993-3_10     Document Type: Chapter

References (64)

1. Eggermont AM, Brunstein F, Grunhagen D, ten Hagen TL (2004) Regional treatment of metastasis: role of regional perfusion. State of the art isolated limb perfusion for limb salvage. Ann Oncol 15 Suppl 4:iv107-12
2. Hildebrandt B, Hegewisch-Becker S, Kerner T, Nierhaus A, Bakhshandeh-Bath A, Janni W, et al (2005) Current status of radiant whole-body hyperthermia at temperatures > 41.5°C and practical guidelines for the treatment of adults. The German "Interdisciplinary Working Group on Hyperthermia". Int J Hyperthermia 21(2):169-183
3. Stewart JHt, Shen P, Levine EA (2005) Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol 12(10):765-777
4. van Der Zee J (2002) Heating the patient: a promising approach? Ann Oncol 13(8):1173-1184
5. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, et al (2002) Hyperthermia in combined treatment of cancer. Lancet Oncol 3(8):487-497
6. Sugarbaker PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7(1):69-76
7. Lagendijk JJ, Van Rhoon GC, Hornsleth SN, Wust P, De Leeuw AC, Schneider CJ, et al (1998) ESHO quality assurance guidelines for regional hyper-thermia. Int J Hyperthermia 14(2):125-133
8. Jones EL, Prosnitz LR, Dewhirst MW, Vujaskovic Z, Samulski TV, Oleson JR, et al (2005) In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153)
9. Int J Radiat Oncol Biol Phys 63(2):644
10. van der Zee J, van Rhoon GC, Wust P (2005) In regard to Dr. Vasanthan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153)
11. Int J Radiat Oncol Biol Phys 1;62(3):940-941
12. Vasanthan A, Mitsumori M, Park JH, Zhi-Fan Z, Yu-Bin Z, Oliynychenko P, et al (2005) Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys 1;61(1):145-153
13. Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al (2003) Randomized trial of cytoreduction and hyperthermic intraperi-toneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 15;21(20):3737-3743
14. Yonemura Y, de Aretxabala X, Fujimura T, Fushida S, Katayama K, Bandou E, et al (2001) Intraoperative chemohyperthermic peritoneal perfusion as an adjuvant to gastric cancer: final results of a randomized controlled study. Hepatogastroenterology 48(42):1776-1782
15. Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ (2003) Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hyperthermia 19(3):267-294
16. Dewey WC (1994) Arrhenius relationships from the molecule and cell to the clinic. Int J Hyperthermia 10(4):457-483
17. Hildebrandt B, Rau B, Gellermann J, Wust P, Riess H (2004) Hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinosis. J Clin Oncol 15;22(8):1527-1529
18. Issels R, Prenninger SW, Nagele A, Boehm E, Sauer H, Jauch K-W, et al (1990) Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas. J Clin Oncol 11:1818-1829
19. Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, et al (2005) Randomized trial of hyperthermia and radiation for superficial tumours. J Clin Oncol 1;23(13):3079-3085
20. Sapareto SA, Dewey WC (1984) Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 10(6):787-800
21. Tilly W, Wust P, Rau B, Harder C, Gellermann J, Schlag P, et al (2001) Temperature data and specific absorption rates in pelvic tumours: predicitve factors and correlations. Int J Hyperthermia 17(2):172-188
22. Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, et al (2002) The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 43(1):33-56
23. Lepock JR (2005) How do cells respond to their thermal environment? Int J Hyperthermia 21(8):681-687
24. Li GC, Mivechi NF, Weitzel G (1995) Heat shock proteins, thermotolerance, and their relevance for clinical hyperthermia. Int J Hyperthermia 11(4):459-488
25. Corry PM, Armour EP (2005) The heat shock response: role in radiation biology and cancer therapy. Int J Hyperthermia 21(8):769-778
26. Dewhirst MW, Vujaskovic Z, Jones E, Thrall D (2005) Re-setting the biologic rationale for thermal therapy. Int J Hyperthermia 21(8):779-790
27. Dewey WC (1989) Mechanism of thermal radiosenzitation. In: Urano M, Douple E, editors. Biology of thermal potentiation of radiotherapy. Utrecht, Tokyo: VSP; p1-16
28. Vujaskovic Z, Song CW (2004) Physiological mechanisms underlying heat-induced radiosensitization. Int J Hyperthermia 20(2):163-174
29. Myerson RJ, Roti Roti JL, Moros EG, Straube WL, Xu M (2004) Modelling heat-induced radiosensitization: clinical implications. Int J Hyperthermia 20(2):201-212
30. Lepock JR (2003) Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage. Int J Hyperthermia 19(3):252-266
31. Coss RA, Linnemanns WAM (1996) The effects of hyperthermia on the cytoskeleton: a review. Int J Hyperthermia 12(2):173-196
32. Kampinga HH, Dynlacht JR, Dikomey E (2004) Mechanism of radiosensitiza-tion by hyperthermia (> or = 43 degrees C) as derived from studies with DNA repair defective mutant cell lines. Int J Hyperthermia 20(2):131-139
33. Borrelli MJ, Garlini WG, Ransom BR, Dewey WC (1986) A direct correlation between hyperthermia induced membrane blebbing and survival in synchronous G1 CHO cells. J Cell Physiol 126:181-190
34. Yonezawa M, Otsuka T, Matsui N, Tsuji H, et al (1996) Hyperthermia induces apoptosis in malignant fibrous histiocytoma cells in vitro. Int J Cancer 66(3):347-351
35. Sakaguchi Y, Stephens LC, Makino M, Kaneko T, et al (1995) Apoptosis in tumours and normal tissues induced by whole body hyperthermia in rats. Cancer Res 55(22): 5459-5464
36. Harima Y, Nagata K, Harima K, Oka A, Ostapenko VV, Shikata N, et al (2000) Bax and Bcl-2 protein expression following radiation therapy versus radiation plus thermoradiotherapy in stage IIIB cervical carcinoma. Cancer 1;88(1):132-138
37. Sturm I, Rau B, Schlag PM, Wust P, Hildebrandt B, Riess H, et al (2006) Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy. BMC Cancer 10;6(1):124
38. Sharma HS, Hoopes PJ (2003) Hyperthermia induced pathophysiology of the central nervous system. Int J Hyperthermia 19(3):325-354
39. Edwards MJ, Saunders RD, Shiota K (2003) Effects of heat on embryos and foetuses. Int J Hyperthermia 19(3):295-324
40. Folkman J (1990) What is evidence that tumors are angiogenesis dependent ? J Natl Cancer Inst 82:4-6
41. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 49(23):6449-6465
42. von Ardenne M, Reitnauer PG (1982) Manipulated selective inhibition of microcirculation in cancer tissues, Article in German. J Cancer Res Clin Oncol 103(3):269-279
43. Song CW, Park HJ, Lee CK, Griffin R (2005) Implications of increased tumour blood flow and oxygenation caused by mild temperature hyperthermia in tumour treatment. Int J Hyperthermia 21(8):761-767
44. Hildebrandt B, Wust P, Drager J, Ludemann L, Sreenivasa G, Tullius SG, et al (2004) Regional pelvic hyperthermia as an adjunct to chemotherapy (oxaliplatin, folinic acid, 5-fluorouracil) in pre-irradiated patients with locally recurrent rectal cancer: a pilot study. Int J Hyperthermia 20(4):359-369
45. Ollek JT, Wlodarczyk W, Ludemann L, Gellerman J, Hildebrandt B, Wust P (2006) Evaluation of perfusion changes induced by hyperthermia using DCE-MRI. 23rd Annual Meeting of the European Society for Hyperthermic Oncology; May 24-27th, 2006; Berlin; p. 80
46. Calderwood SK, Theriault JR, Gong J (2005) How is the immune response affected by hyperthermia and heat shock proteins? Int J Hyperthermia 21(8):713-716
47. Chen Q, Evans SS (2005) Thermal regulation of lymphocyte trafficking: hot spots of the immune response. Int J Hyperthermia 21(8):723-729
48. Atanackovic D, Nierhaus A, Neumeier M, Hossfeld DK, Hegewisch-Becker S (2002) 41.8 degrees C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases. Cancer Immunol Immunother 51(11-12):603-613
49. Katschinski D, Wiedemann GJ, Longo W, d'Oleire FR, Spriggs D, Robins HI (1999) Whole body hyperthermia cytokine induction: a review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy. Cytokine Growth Factor Rev 10(2):93-97
50. Robins HI, Kutz M, Wiedemann GJ, Katschinski DM, Paul D, Grosen E, et al (1995) Cytokine induction by 41.8 degrees C whole body hyperthermia. Cancer Lett 97:195-201
51. Bouchama A, Knochel JP (2002) Heat stroke. N Engl J Med 20;346(25):1978-1988
52. Zellner M, Hergovics N, Roth E, Jilma B, Spittler A, Oehler R (2002) Human monocyte stimulation by experimental whole body hyperthermia. Wien Klin Wochenschr 15;114(3):102-107
53. Ahlers O, Hildebrandt B, Dieing A, Deja M, Bohnke T, Wust P, et al (2005) Stress induced changes in lymphocyte subpopulations and associated cyto-kines during whole body hyperthermia of 41.8-42.2 degrees C. Eur J Appl Physiol 95(4):298-306
54. Dieing A, Ahlers O, Kerner T, Wust P, Felix R, Loffel J, et al (2003) Whole body hyperthermia induces apoptosis in subpopulations of blood lymphocytes. Immunobiology 207(4):265-273
55. Kregel KC (2002) Heat Shock proteins: modifying factors in physiological stress response and aquired thermotolerance. J Appl Physiol 92:2177-2186
56. Jolly C, Morimoto RI (2000) Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J Natl Cancer Inst 92(19):1564-1572
57. Jaattela M (1999) Heat shock proteins as cellular lifeguards. Ann Med 31:261271
58. Srivastava P (2002) Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol 2(3):185-194
59. Multhoff G (2002) Activation of natural killer cells by heat shock protein 70. Int J Hyperthermia 18(6):576-585
60. Gehrmann M, Marienhagen J, Eichholtz-Wirth H, Fritz E, Ellwart J, Jaattela M, et al (2005) Dual function of membrane-bound heat shock protein 70 (Hsp70), Bag-4, and Hsp40: protection against radiation-induced effects and target structure for natural killer cells. Cell Death Differ 12(1):38-51
61. Krause SW, Gastpar R, Andreesen R, Gross C, Ullrich H, Thonigs G, et al (2004) Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial. Clin Cancer Res 10(11):3699-3707
62. Li CY, Dewhirst MW (2002) Hyperthermia-regulated immunogene therapy. Int J Hyperthermia 18(6):586-596
63. Streffer C (1990) Biological basis of thermotherapy (with special reference to oncology). In: Gautherie M, editor. Biological basis of oncologic thermother-apy. Berlin, Heidelberg, New York: Springer; p1-72
64. Raaphorst GP (1989) Thermal radiosenzitation in vitro. In: Urano M, Douple E, editors. Biology of thermal potentiation of radiotherapy. Utrecht, Tokyo: VSP; p17-52